The second pathway present in both mid-stage and late-stage CRC cells; POLQ is modified by mutation (Lin et al., 2000; Nilsson et al., 2001); target gene p53-induced death domain protein 1 (PIDD1) is downregulated by TF LIG1 which promotes tumor apoptosis. Here, POLQ is linked to neoplasm.